Safety Study of SRX251 Capsules in Healthy Female Volunteers
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of SRX251 when given orally. The amount
of SRX251 in the blood will also be measured. Healthy women, ages 18-50 years who have been
surgically sterilized by tubal ligation, will be enrolled in this study.